RCUS
Arcus Biosciences, Inc. · Healthcare
CFO II Robert C. Goeltz sold $40K of Arcus Biosciences, Inc.
Sold$40,080
$20.00Price
2,004Shares
−4%Stake
What RCUS did after the filing
- The stock from Thu, Jan 4 close, $19.00
- −11.6%
- S&P 500, same days
- +6.9%
Measured over 30 trading days, to the Feb 16 close.
Traded Tue, Jan 2. Filed Thu, Jan 4, 12:23 PM ET, during the session. Returns use the Jan 4 close and the Feb 16 close. Not investment advice.